Menu

CLINICAL HEMATOLOGY

Haematology is the science dealing with all problems of the blood either (benign or malignant), immunity (deficiency-inherited or acquired/ autoimmunity).

At Healthway the department is run by our highly qualified consultant Dr. Vijay Ramanan, D.M Clinical Haematology / Haem-Oncology / Bone marrow transplant Physician. He has conducted over 350 transplants and is First individual Patron of European Society of blood and bone marrow transplant in India.

Following conditions are managed by the department

  • R.B.Cs related disorders or deficiency of hemoglobin Anemia,Thalassaemia, Myelodysplastic Syndrome/ Leukaemia/Polycythemia.
  • W.B.Cs-related disorders or deficiency of functions-immunodeficiency/ Leukaemia-A.M.L or A.L.L/chronic myeloid leukaemia, Chronic lymphocytic leukaemia, Myeloma, Lymphoma-Hodgkin or non-Hodgkins.
  • Platelets Deficiency disorders -Immune thrombocytopenia, Aplastic Anemia or excess-Myelofibrosis and Essential thrombocytosis.
  • Coagulation factors-Disorders like Hemophilia/ excessive clotting factors like deep vein thrombosis or arterial thrombosis and disseminated intravascular coagulation.In addition we have 24 hour emergency services through which any haematological patient can be evaluated and treated round the clock.We have 24 x 7 laboratory services required in diagnosis and follow up of haematological conditions and chemotherapy facility too

DOCTORS

Dr. Vijay Ramanan

Consultant Anaesthesiologist & Intensivist

Dr.Nehal

Qualification

  1. MBBS (Bombay University)
  2. MD (New York, USA)
  3. Master’s in Public Health (New York, USA)
  4. D.M. (Hematology) (New York, USA)
  5. D.M. (Medical Oncology) (New York, USA)
  6. F.A.C.P. (U.S.A.

Membership

  1. American Society of Blood and Marrow Transplantation
  2. American Society of Clinical Oncology
  3. American Society of Hematology
  4. American College of Physicians
  1. 3/2017 Pinto IG. Systemic therapy in bladder cancer. Indian J Urol 2017;33:118-26
  2. 07/2015 Pinto et al A retrospective analysis ALK-positive non-small-cell lung carcinoma.
  3. European Journal of Cancer. July 2015. Volume 51, Supplement 2, Page e22.
  4. 04/2015 Retrospective review of patients with ALK + Non-Small Cell Lung cancer. Oral and
  5. poster presentation at Asian Oncology Summit, Lancet Oncology, Shanghai, China.
  6. 04/2015 Pinto et al New Oral Anticoagulants and their reversal. Current Drug Safety 2015; 10 (3),208-16
  7. 07/2014 Pinto et al Concurrent crizotinib and whole brain radiation for brain metastases in
  8. ALK positive lung adenocarcinoma. Lung Cancer Management (2014)3(5), 369-371
  9. 04/2014 Adjuvant chemotherapy in the elderly with Non-small cell lung cancer
  10. American Association for Cancer Research Annual Meeting (Abstract presentation)
  1. Chief fellow, Hematology-Oncology Fellowship Program, State University of New York, USA
  2. Fellow of American College of Physicians (FACP), New York, USA
  3. Housestaff Physician Leadership Award, New York, USA
  4. President of Housestaff Physician Association, New York, USA
  5. 2nd Prize for Research Presentation at Strong Hospital, University of Rochester
  6. Scholarship Tagore Educational Society for highest score in Internal Medicine, Mumbai, India
  7. Certificate of Honor from St. Luke’s Medical Guild for highest score in Final M.B.B.S., Mumbai,
    India